PubMed:20040515 / 162-283 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":121},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":121},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":121},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T1","span":{"begin":3,"end":11},"obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"DisGeNET","denotations":[{"id":"T2","span":{"begin":58,"end":68},"obj":"gene:3958"},{"id":"T3","span":{"begin":88,"end":98},"obj":"disease:C0006826"},{"id":"T4","span":{"begin":58,"end":68},"obj":"gene:3958"},{"id":"T5","span":{"begin":25,"end":38},"obj":"disease:C0678222"},{"id":"T6","span":{"begin":58,"end":68},"obj":"gene:3958"},{"id":"T7","span":{"begin":25,"end":38},"obj":"disease:C0006142"},{"id":"T8","span":{"begin":58,"end":68},"obj":"gene:3958"},{"id":"T9","span":{"begin":88,"end":98},"obj":"disease:C1306459"},{"id":"T10","span":{"begin":58,"end":68},"obj":"gene:3958"},{"id":"T11","span":{"begin":103,"end":120},"obj":"disease:C0178874"}],"relations":[{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"},{"id":"R3","pred":"associated_with","subj":"T4","obj":"T5"},{"id":"R4","pred":"associated_with","subj":"T6","obj":"T7"},{"id":"R5","pred":"associated_with","subj":"T8","obj":"T9"},{"id":"R6","pred":"associated_with","subj":"T10","obj":"T11"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":13,"end":38},"obj":"HP_0100615"},{"id":"T2","span":{"begin":25,"end":38},"obj":"HP_0003002"},{"id":"T3","span":{"begin":25,"end":38},"obj":"HP_0100013"},{"id":"T4","span":{"begin":32,"end":38},"obj":"HP_0002664"},{"id":"T5","span":{"begin":103,"end":108},"obj":"HP_0002664"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T5","span":{"begin":3,"end":11},"obj":"FMAID:97485"},{"id":"_T6","span":{"begin":3,"end":11},"obj":"FMAID:9600"},{"id":"_T7","span":{"begin":25,"end":31},"obj":"FMAID:9601"},{"id":"_T8","span":{"begin":25,"end":31},"obj":"FMAID:97486"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"uniprot-human","denotations":[{"id":"T2","span":{"begin":58,"end":68},"obj":"http://www.uniprot.org/uniprot/P17931"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"uniprot-mouse","denotations":[{"id":"T2","span":{"begin":58,"end":68},"obj":"http://www.uniprot.org/uniprot/P16110"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T4","span":{"begin":32,"end":38},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/6754"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"UBERON-AE","denotations":[{"id":"T1","span":{"begin":25,"end":31},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"EDAM-topics","denotations":[{"id":"T2","span":{"begin":32,"end":38},"obj":"http://edamontology.org/topic_2640"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"20040515-2#58#68#gene3958","span":{"begin":58,"end":68},"obj":"gene3958"},{"id":"20040515-2#103#120#diseaseC0178874","span":{"begin":103,"end":120},"obj":"diseaseC0178874"}],"relations":[{"id":"58#68#gene3958103#120#diseaseC0178874","pred":"associated_with","subj":"20040515-2#58#68#gene3958","obj":"20040515-2#103#120#diseaseC0178874"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"GlycoBiology-MAT","denotations":[{"id":"T1","span":{"begin":3,"end":11},"obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T3","span":{"begin":25,"end":31},"obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"mondo_disease","denotations":[{"id":"T3","span":{"begin":25,"end":38},"obj":"Disease"},{"id":"T4","span":{"begin":88,"end":108},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"Anatomy-MAT","denotations":[{"id":"T1","span":{"begin":3,"end":11},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"mat_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MAT_0000078"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"HP-phenotype","denotations":[{"id":"T2","span":{"begin":25,"end":38},"obj":"Phenotype"},{"id":"T3","span":{"begin":103,"end":108},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0003002"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":3,"end":11},"obj":"Body_part"},{"id":"T2","span":{"begin":25,"end":31},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002367"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"In prostate, ovarian and breast cancer, downregulation of galectin-3 is associated with malignancy and tumor progression."}